Products
Platform
Research
Market
Learn
Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.05 | 1.93 |
NAV | ₹19.76 | ₹433.77 |
Fund Started | 06 Oct 2020 | 04 Jun 1999 |
Fund Size | ₹165.54 Cr | ₹4026.55 Cr |
Exit Load | - | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.05
1.93
NAV
₹19.76
₹433.77
Fund Started
06 Oct 2020
04 Jun 1999
Fund Size
₹165.54 Cr
₹4026.55 Cr
Exit Load
-
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 2.15% | 10.79% |
3 Year | 17.76% | 26.58% |
5 Year | - | 20.29% |
1 Year
2.15%
10.79%
3 Year
17.76%
26.58%
5 Year
-
20.29%
Holding Analysis
Equity | 99.76% | 97.60% |
Cash | -0.01% | 2.33% |
Equity
99.76%
97.60%
Cash
-0.01%
2.33%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.45% |
Max Healthcare Institute Ltd. | 6.77% |
Cipla Ltd. | 6.14% |
Divi's Laboratories Ltd. | 5.51% |
Apollo Hospitals Enterprise Ltd. | 5.28% |
Dr. Reddy's Laboratories Ltd. | 5.19% |
Eli Lilly And Co | 4.98% |
Johnson & Johnson Ltd. | 3.31% |
Torrent Pharmaceuticals Ltd. | 3.10% |
Lupin Ltd. | 3.08% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.44% |
Divi's Laboratories Ltd. | 7.21% |
Max Healthcare Institute Ltd. | 6.50% |
Cipla Ltd. | 4.63% |
Lonza Group Ag | 4.09% |
Lupin Ltd. | 4.02% |
Gland Pharma Ltd. | 3.59% |
Mankind Pharma Ltd. | 3.57% |
Acutaas Chemicals Ltd. | 3.30% |
Krishna Institute of Medical Sciences Ltd | 3.26% |
Fund Manager
Name | Bhavesh Jain | Tanmaya Desai |
Start Date | 01 Oct 2021 | 27 Jun 2011 |
Name
Bhavesh Jain
Tanmaya Desai
Start Date
01 Oct 2021
27 Jun 2011
About Fund
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 06 Oct 2020 | 04 Jun 1999 |
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
06 Oct 2020
04 Jun 1999
